Transchem — 360° view

Transchem, a company in the Pharmaceuticals industry, reported revenue of ₹0.93 crore and net profit of ₹2.05 crore for the September 2026 quarter.

Transchem (BSE: TRANSCHEM) closed at ₹411.05 on 20 Nov 2026, up 451.9% over the past year. Its market capitalisation is ₹503 crore and it trades at 88.7 times earnings.

Share price
₹411.05 (20 Nov 2026)
Market cap
₹503 Cr (20 Nov 2026)
P/E
88.74 (20 Nov 2026)
Revenue
₹1 Cr (September 2026 quarter)
Net profit
₹2 Cr (September 2026 quarter)
ROCE
6.90% (FY26)
ROE
5.29% (FY26)
Book value
₹167 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹433.00 / ₹75.00 (20 Nov 2026)
1-year return
451.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: TRANSCHEM

Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.